Year: 2022

news_6

CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone

BEIJING & CAMBRIDGE, Mass.--(BUSINESS WIRE)--CANbridge Pharmaceuticals, Inc. (“CANbridge”, stock code 1228.HK), a leading China-based global rare disease-focused biopharmaceutical company committed...

news_6

Natural Language Processing (NLP) Industry Assessment and Forecast 2022-2027 by Type, Technology, Deployment Mode, Organization Size, End-user, and Region – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Natural Language Processing (NLP) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been...

news_6

Asia-Pacific Sleep Apnea Therapeutics and Diagnostics Market (2021 to 2028) – Featuring BMC Medical, Cadwell Industries and Devilbiss Healthcare Among Others – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "APAC Sleep Apnea Therapeutics and Diagnostics" report has been added to ResearchAndMarkets.com's offering. The market for sleep apnea...

news_6

Renesas Develops Bluetooth Low Energy RF Transceiver Technologies That Simplify Board Design, Reduce Circuit Size and Increase Power Efficiency

Announced at ISSCC 2022: Impedance Tuning and Reference Signal Self-Correction Technologies Can Facilitate Bluetooth LE Implementation in IoT Devices TOKYO--(BUSINESS...